➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: July 13, 2020

DrugPatentWatch Database Preview

Patent: 9,651,560

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,651,560

Title:	Methods for detecting antibodies
Abstract:	The present invention relates to methods of detecting Anti-Drug Antibodies. The present invention also relates to methods of monitoring patients undergoing therapeutic antibody treatment. The invention further relates to kits suitable for the implementation of the above methods.
Inventor(s):	Parussini; Ermis (Lentilly, FR), Noguier; Guillaume (Bussy Saint George, FR)
Assignee:	THERADIAG SA (Croissy-Beaubourg, FR)
Application Number:	14/745,765
Patent Claims:	see list of patent claims

Details for Patent 9,651,560

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Janssen Biotech	SIMPONI ARIA	golimumab	INJECTABLE; INJECTION	125433	001	2013-07-18	Start Trial	THERADIAG SA (Croissy-Beaubourg, FR)	2030-04-29	RX		search
Centocor Ortho Biotech Inc	SIMPONI	golimumab	INJECTABLE; INJECTION	125289	001	2009-04-24	Start Trial	THERADIAG SA (Croissy-Beaubourg, FR)	2030-04-29	RX	Orphan	search
Ucb Inc	CIMZIA	certolizumab pegol	INJECTABLE; INJECTION	125160	001	2008-04-22	Start Trial	THERADIAG SA (Croissy-Beaubourg, FR)	2030-04-29	RX		search
Abbvie Inc	HUMIRA	adalimumab	VIAL	125057	002	2002-12-31	Start Trial	THERADIAG SA (Croissy-Beaubourg, FR)	2030-04-29	RX		search
Abbvie Inc	HUMIRA	adalimumab	SYRINGE	125057	001	2002-12-31	Start Trial	THERADIAG SA (Croissy-Beaubourg, FR)	2030-04-29	RX		search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patent Family for US Patent 9,651,560

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2011135024	Start Trial
United States of America	2011269884	Start Trial
United States of America	2013108631	Start Trial
United States of America	2015285815	Start Trial
United States of America	9029475	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Dow

Medtronic

Baxter

Colorcon

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.